Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) Ticker Search
Pro Search
Index Search
 QQQ: 73.45 -0.23%   SPY: 165.45 -0.29% FAQ | Sign Up Now | Login
Profile Portfolio Notes & Links Tracked By  


  Track this member and follow their portfolio moves with tickerspy™ alerts  

kenb


Portfolio List (10):
biotechmed


Close
goto  -0.0%
Tech  -0.2%
maritime  0.0%
finance  0.0%
Test 1  0.2%
Alt Energy  2.0%
biotechmed  0.0%
Number 1    0.0%

  Performance       Ideas       Community  
 
Today:
Week:
1-month:
All-time: 		0.0%
+0.9%
+6.1%
+182.6% 		vs S&P 500:
vs S&P 500:
vs S&P 500:
vs S&P 500: 		+0.3%
+1.8%
+1.3%
+94.1%
     
Similar Portfolios also own:
ONXX, CELG, [GENZ], PGNX, REGN, [CLDA], AMGN, SPPI, AVNR, BIIB
 
     
Share this portfolio on Facebook
Share this portfolio on Twitter
 
                     
     
 
Chart View
1 week
  
1 month
  
3 months
  
6 months
  
All Time
  
 
 

 
 
 
 
   
     
 
Portfolio Detail
 
  Standard View     Performance View     Portfolio HistoryNEW    
Click a column to sort | Scroll over columns for more information
What are Alerts?
  
 Ticker Last Trade Today's Change Volume  % of
Daily		 Mkt Cap  Div Yield  % off
52wk lw		 % from
52wk hg		 Gain View as: Alerts Comments
 ABMD $21.72 -0.11 -0.5% 610,865 146% $848.7M - 84% -13% +141.6%
 [AMLN] $0.00 0.00 0.0% 0% $ - N/A% N/A% -100.0%
 ANDS $3.70 0.00 0.0% 169,153 5% $ - 517% 0% -37.5%
 ARNA $8.06 +0.14 +1.8% 4,177,986 79% $1.7B - 39% -40% +109.9%
 ASTM $0.56 -0.01 -1.8% 363,421 134% $24.9M - 8% -76% -86.5%
 BHRT $0.03 +0.01 +19.6% 1,506,611 177% $5.2M - 560% -42% -96.6%
 [BMTI] $0.00 0.00 0.0% 0% $ - N/A% N/A% -100.0%
 BSX $9.16 +0.03 +0.3% 23,811,358 115% $12.3B - 91% -2% +6.6%
 EPIX $0.00 0.00 0.0% 100 1% $ - N/A% N/A% -100.0%
 FOLD $3.42 -0.04 -1.2% 447,040 122% $171.7M - 38% -50% -57.2%
 GNVC $0.70 0.00 0.0% 16,682 14% $9.0M - 11% -75% +66.7%
 [HGSI] $0.00 0.00 0.0% 0% $ - N/A% N/A% -100.0%
 IMGN $17.74 +0.71 +4.2% 699,162 83% $1.4B - 64% -2% +242.5%
 INSY $10.41 +0.23 +2.3% 52,897 57% $4.7M - 59% -42% +162.5%
 ISIS $20.64 +0.25 +1.2% 1,105,351 61% $2.0B - 173% -10% +46.4%
 ITMN $9.96 +0.36 +3.8% 1,126,653 78% $784.1M - 38% -22% +6.6%
 MDCO $33.32 +0.79 +2.4% 1,417,841 139% $1.8B - 66% -11% +104.8%
 MRGE $3.30 +0.04 +1.2% 241,182 77% $304.4M - 50% -19% +86.4%
 NBIX $12.71 +0.70 +5.8% 693,594 124% $801.2M - 103% -1% +248.2%
 OREX $6.48 +0.29 +4.7% 1,790,864 215% $573.4M - 109% -16% +6.6%
 OSIR $11.07 +0.09 +0.8% 78,794 75% $361.5M - 101% -23% -43.5%
 PARD $0.21 0.00 0.0% 181 17% $1.5M - 5% -78% -99.8%
 PRGX $5.46 +0.09 +1.7% 74,412 43% $154.9M - 14% -38% +36.8%
 RGEN $8.50 +0.27 +3.3% 341,169 86% $258.6M - 128% -12% +99.1%
 RIGL $4.64 +0.13 +2.9% 993,522 110% $393.0M - 5% -59% -45.2%
 SNTA $7.31 -0.08 -1.1% 498,767 53% $510.8M - 93% -38% +6.6%
 VPHM $26.44 +0.34 +1.3% 630,313 99% $1.7B - 36% -16% +327.1%
 VVUS $14.50 +0.98 +7.2% 6,741,761 264% $1.3B - 47% -54% +184.9%
Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Discuss this portfolio with kenb
 
Latest Portfolio Notes & Links
 
View: Headlines   |   Message Board   |   Portfolio Notes  
 
 
Repligen CEO to Present at Jefferies 2013 Global Healthcare Conference
RGEN  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 23, 01:43PM from (globenewswire.com)
WALTHAM, Mass., May 23, 2013 (GLOBE NEWSWIRE) -- Repligen Corporation (Nasdaq:RGEN) today announced that Walter C. Herlihy,  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
First Manhattan Adds Alex Denner to Vivus Board Slate
VVUS  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 23, 06:30AM from (www.businesswire.com)
First Manhattan Co. (“FMC”), an owner-managed and operated investment advisory firm and the beneficial holder of approximately  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Medtronic Still Reporting Weak Growth, But A Relatively Rare Bargain
MDT  JNJ  STJ  BSX  
Linked by Investopedia Stock Analysis ( track newsfeed | ignore newsfeed ) - May 22, 11:30AM from (www.investopedia.com)
Medtronic continues to suffer with weak core markets, but business seems to be getting slowly better and valuation is not  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Boston Scientific's Lotus Aortic Valve Shows Promise in Study
MDT  BSX  EW  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 22, 11:05AM from (www.bloomberg.com)
Boston Scientific Corp. (BSX)’s Lotus device, inserted through a catheter into the heart to fix a damaged aortic valve,  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
VIVUS Announces Scientific Presentations
VVUS  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 22, 07:13AM from (globenewswire.com)
MOUNTAIN VIEW, Calif., May 22, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Top New Biotech Ideas from PropThink
CELG  REGN  CBST  VPHM  ONXX  AVEO  MAKO  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 16, 07:30AM from (247wallst.com)
The world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug Administration (FDA)  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Amicus Therapeutics to Present at UBS Global Healthcare Conference
FOLD  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 14, 10:43AM from (globenewswire.com)
CRANBURY, N.J., May 14, 2013 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD) today announced that John F. Crowley,  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
VIVUS Announces Scientific Presentations
VVUS  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 14, 07:13AM from (globenewswire.com)
MOUNTAIN VIEW, Calif., May 14, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Mid-Day Market Update: US Stocks Fall on Monday, Gold Down
AA  INTC  ELN  GNVC  THRX  EOX  RCON  TSLA  SCTY  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 13, 01:18PM from (www.benzinga.com)
Midway through trading Monday, the Dow fell 0.20 percent to 15,089. The NASDAQ rose 0.22 percent to 3,444.14, while the S&P rose 0.04 percent to 1,634.41.
 more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Mid-Morning Market Update: April Retail Sales Beat Expectations, Business Inventories for March Show a Decline
KUB  ELN  GNVC  CIMT  THRX  PLG  NBG  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 13, 10:53AM from (www.benzinga.com)
Following the market opening Monday, the Dow traded down 0.26 percent to 15,079.29, while the NASDAQ diped 0.10 percent to  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
VIVUS Mails Letter to Stockholders Providing Business Update
VVUS  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 13, 07:13AM from (globenewswire.com)
MOUNTAIN VIEW, Calif., May 13, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the "Company") today mailed  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
VIVUS Appoints J. Martin Carroll and Jorge Plutzky, M.D. to Board of Directors
VVUS  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 13, 07:13AM from (globenewswire.com)
MOUNTAIN VIEW, Calif., May 13, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced the appointment of J. Martin  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Short Interest in Vertex Rises, in Celgene Falls
BMY  PFE  JNJ  MRK  AMGN  CELG  REGN  BIIB  VRTX  VVUS  GILD  ALXN  PCYC  ONXX  ARNA  DNDN  ILMN  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 11, 10:45AM from (www.benzinga.com)
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April.
 more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Kyrgyzstan Decries Dismissal of U.S. Case Against Bakiyev
TYC  ITMN  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 10, 07:47PM from (www.bloomberg.com)
Kyrgyzstan is “disappointed” with the dismissal of a U.S. criminal case against the son of ousted former leader Kurmanbek  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
APB Financial Group and Hedge Fund Solutions to Host Webcast to Discuss First Manhattan Co's Activist Investment in VIVUS, Inc.
VVUS  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 10, 12:43PM from (globenewswire.com)
NEW YORK, May 10, 2013 (GLOBE NEWSWIRE) -- APB Financial Group today announced that Damien Park, Managing Partner at Hedge  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
U.S. Case Ends Against Ex-Kyrgyz Leader Bakiyev's Son
TYC  ITMN  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 09, 09:10PM from (www.bloomberg.com)
A U.S. criminal securities fraud case against Maksim Bakiyev, the son of former Kyrgyzstan leader Kurmanbek Bakiyev, has  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Closing Bell for Wednesday on Wall Street: Markets Open Lower, Stock Prices Rise All Day
CMA  WEN  MRO  CDE  AMGN  KGC  EA  CLR  PEIX  FTEK  MNST  VVUS  BBBY  ENB  AGU  DISH  CVC  PAA  RAX  AFFY  SD  LULU  AWK  RIG  AOL  TSLA  DMD  FIO  Z  GRPN  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 08, 04:05PM from (247wallst.com)
U.S. equity markets opened lower this morning on relatively little economic data. In Europe, Germany reported that industrial  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
The New Diet Pill Players: Arena and Vivus
ABT  VVUS  AZN  ARNA  
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - May 08, 01:43PM from (ycharts.com)
Over the past 24 hours, two developments finally occurred to suggest overweight consumers will soon have an expanding choice  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Vivus in Talks With Potential Marketing Partners, CEO Says
VVUS  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 08, 12:10PM from (www.bloomberg.com)
Vivus Inc. (VVUS), maker of the obesity drug Qsymia, is in talks with large pharmaceutical companies to explore ways to increase  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 134



Home | About | Register | My tickerspy | Logout Web site design by LightMix
© 2007-2013 Indie Research, LLC. All rights reserved.  

 

---
The information herein is provided by various sources including individual contributors not associated with Indie Research and is not guaranteed by us and does not purport to be a complete or error-free statement or summary of the available data. As such, we do not warrant, endorse or guarantee the completeness, accuracy, integrity or timelines of the information. You must evaluate, and bear all risks associated with, the use of any information provided hereunder, including any reliance on the accuracy, completeness, safety or usefulness of such information. This information is not intended to be used as the primary basis of investment decisions. It should not be construed as financial or other advice or as an offer to sell or the solicitation of an offer to buy any security in any state where such an offer or solicitation would be illegal. Any information expressed herein on this date is subject to change without notice. Any opinions or assertions contained in this information do not represent the opinions or beliefs of Indie Research, LCC or one or more of its employees, may have a position in any of the securities discussed herein. Use of the tickerspy.com, signifies your agreement to the Terms of Use.

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.

THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF.


Market Data Powered by Interactive Data
Terms and Conditions

Close [X]  
Post a description about this portfolio.
(150 character limit)

Click to close X

Use portfolios to track tickers you're interested in. News related to your tickers will appear below the portfolio. Tickers in your portfolios will generate Alerts on your tickerspy Alerts page.

The Recent Tickers portfolio saves the tickers you've recently viewed on the site.
Click to close X

By matching similar portfolios, tickerspy helps members find institutional and individual investors with strategies similar to their own.
Click to close X

Portfolio performance for tickerspy member portfolios is calculated by equally weighting all of the stocks held in the portfolio.
Click to close X

Performance View offers a snapshot of how individual portfolio positions have performed since being added (or shorted) as well as a look at the individual stocks' performance over various time periods. In the case of "shorts," a decline in price will result in a positive gain.

Portfolio History offers a view of all current and past holdings in a portfolio.
Click to close X

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.
Click to close X

To calculate "all-time" Pro performance, we combine all of the quarterly holdings reports for that Pro investor. The initial date used is the start date of the first quarterly holdings report we have in our database. Start dates vary based on the first quarterly holdings report we have for each Pro. Please see our Institutional Holdings Disclaimer (located at the bottom of this page) for more on how we calculate Pro portfolio performance estimates. tickerspy is not affiliated with any of Pro investors profiled on our web site.
Click to close X

Your primary portfolio will appear in other member’s Tracking Hubs when they track your performance. Your primary portfolio is also used in our Ideas & Research section, where your portfolio is compared with the portfolios of other members, and elsewhere on the site where other portfolio comparisons are made.

Note: Primary portfolios must contain at least five stocks of greater than $1 per share. If you have elected to make your primary portfolio private or if your portfolio is not eligible to be primary, it will not appear in the Ideas & Research section or on the front page.
Click to close X

Primary portfolio

Click to close X
Click the Alerts links in your portfolio to see news from the last 36 hours as well as data alerts displaying unusual price and volume action. You will also see Alerts related to the activity of other tickerspy members. To see more Alerts, visit your customized Alerts page. And for more Alerts info, visit our Alerts FAQ.
Click to close X
The Recent Tickers portfolio saves the tickers you've recently viewed on the site.